Deutsch
A A A
DE
Bereichsnavigation

Previous
Disclosure of voting rights | 02/26/2014

RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


RHÖN-KLINIKUM AG

26.02.2014 16:29

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.




Notification according to section 26 para. 1 WpHG

Morgan Stanley, Wilmington/Delaware, USA notified us pursuant to section 25
WpHG of the following:
On February 19, 2014 Morgan Stanley exceeded the threshold of 5% of the
voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt
a. d. Saale, Germany. On that date, Morgan Stanley held 5.0005% of the
voting rights in RHÖN-KLINIKUM AG (equals 6,912,251 voting rights).
From these voting rights a proportion of 4.96% (equals 6,861,562 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.04% (equals 50,689 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0.04%
(equals 50,689 voting rights) is held indirectly (chain of controlled
undertakings: Morgan Stanley Capital Management LLC; Morgan Stanley
Domestic Holdings Inc.; Morgan Stanley & Co. LLC). The instruments pursuant
to section 25 WpHG are retransfer claims based on various contracts that
can be exercised at the lenders discretion.

In addition, Morgan Stanley, Wilmington/Delaware, USA notified us pursuant
to section 25 WpHG of the following:
On February 20, 2014 Morgan Stanley fell below the threshold of 5% of the
voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt
a. d. Saale, Germany. On that date, Morgan Stanley held 4.92% of the voting
rights in RHÖN-KLINIKUM AG (equals 6,797,558 voting rights).
From these voting rights a proportion of 4.88% (equals 6,746,869 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 0.04% (equals 50,689 voting rights) is based on (financial /
other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0.04%
(equals 50,689 voting rights) is held indirectly (chain of controlled
undertakings: Morgan Stanley Capital Management LLC; Morgan Stanley
Domestic Holdings Inc.; Morgan Stanley & Co. LLC). The instruments pursuant
to section 25 WpHG are retransfer claims based on various contracts that
can be exercised at the lenders discretion.

Bad Neustadt a.d. Saale, February 26, 2014

The Board of Management

___________________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



26.02.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de




Language: English
Company: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Internet: www.rhoen-klinikum-ag.com

End of Announcement DGAP News-Service